Institutional Ownership
Vertex Pharmaceuticals Inc
CUSIP 92532F100COMVRTXQ1 2026
13D / 13G Filings
25
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
11.2%
Max % of class reported
Institutional Holders
1,669
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
25 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Capital Research Global Investors | 13G/A | 6.8% | 17.32M | SEC |
| 2 | May 13, 2025 | Capital Research Global Investors | 13G | 5.7% | 14.54M | SEC |
| 3 | Feb 13, 2025 | Capital World Investors | 13G/A | 11.2% | 28.74M | SEC |
| 4 | Feb 12, 2025 | Fmr LLC | 13G/A | 3.6% | 9.22M | SEC |
| 5 | Apr 10, 2024 | Capital World Investors | 13G/A | 10.0% | 25.90M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 8.7% | 22.28M | SEC |
| 7 | Feb 9, 2024 | Capital World Investors | 13G/A | 8.6% | 22.08M | SEC |
| 8 | Feb 9, 2024 | Fmr LLC | 13G/A | 5.0% | — | SEC |
| 9 | Jan 25, 2024 | Blackrock Inc. | 13G | 8.5% | 21.88M | SEC |
| 10 | Feb 13, 2023 | Capital World Investors | 13G | 5.0% | 12.94M | SEC |
15 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vertex Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Capital World Investors | 25.37M | $11.33B |
| 2 | Blackrock, Inc. | 23.97M | $10.70B |
| 3 | Capital Research Global Investors | 21.13M | $9.43B |
| 4 | State Street Corp | 11.73M | $5.24B |
| 5 | Jpmorgan Chase & Co | 7.03M | $3.12B |
| 6 | Geode Capital Management, LLC | 6.14M | $2.73B |
| 7 | Capital International Investors | 5.13M | $2.29B |
| 8 | Loomis Sayles & Co L P | 4.00M | $1.79B |
| 9 | Alliancebernstein L.P. | 3.91M | $1.77B |
| 10 | Wellington Management Group LLP | 3.21M | $1.43B |